Macrobrachium rosenbergii Nodavirus

Overview and Taxonomy of Macrobrachium rosenbergii Nodavirus

Introduction and Historical Context

Macrobrachium rosenbergii nodavirus (MrNV) is the etiological agent of White Tail Disease (WTD), a devastating condition affecting the giant freshwater prawn, Macrobrachium rosenbergii. Since its initial recognition in the late 1990s, MrNV has emerged as a paramount threat to freshwater prawn aquaculture, a sector of critical economic importance to developing nations across Southeast Asia, the Indian subcontinent, and increasingly, other regions of the world [9, 20]. The disease was first documented in the French West Indies in 1995, and subsequently reported in China, India, Thailand, Indonesia, and Korea, reflecting a rapid and concerning geographic expansion [6, 24, 27]. The pathogen’s impact is catastrophic, particularly in hatcheries and nursery facilities, where infection in larvae and post-larvae (PL) stages can precipitate mortality rates approaching 100% within a matter of days [1, 4, 9, 17]. This extreme virulence has positioned MrNV as a pathogen of major concern to the Food and Agriculture Organization (FAO) of the United Nations, given its direct threat to food security and the livelihoods of smallholder farmers in regions heavily reliant on aquaculture.

The clinical hallmark of WTD is a progressive whitish opacification of the abdominal musculature, a macroscopic sign that belies the extensive myonecrosis occurring at the cellular level [6, 24, 27]. While the disease is most acutely lethal in early life stages, subclinical infections in adult prawns are now recognized as a significant epidemiological factor, facilitating the silent spread of the virus within and between populations [6]. This capacity for covert transmission complicates biosecurity measures and underscores the necessity for a profound understanding of the virus’s biology, from its molecular architecture to its taxonomic standing.

Taxonomic Classification and the Case for a New Genus

The taxonomic placement of MrNV has been a subject of considerable scientific discourse, driven by structural and genomic features that distinguish it from other members of the family Nodaviridae. Historically, the Nodaviridae family was divided into two genera: Alphanodavirus, which infect insects, and Betanodavirus, which infect fish. MrNV, a pathogen of crustaceans, was initially assigned to the Nodaviridae family based on its bipartite, positive-sense single-stranded RNA genome and icosahedral capsid architecture [6, 10]. However, a growing body of high-resolution structural evidence has challenged this classification, strongly advocating for the establishment of a new genus, tentatively designated Gammanodavirus, to accommodate this unique prawn pathogen [14, 20, 22].

The most compelling argument for this reclassification stems from the atomic-resolution structure of the MrNV capsid, solved by cryogenic electron microscopy (cryoEM) at 3.3 Å resolution [14]. This analysis revealed a T=3 icosahedral capsid with a diameter of approximately 30 nm, a feature shared with other nodaviruses [3, 12, 24]. However, the surface architecture is fundamentally divergent. While alphanodaviruses and betanodaviruses assemble capsids adorned with prominent trimeric spikes, the MrNV capsid is characterized by distinctive dimeric, blade-like protruding (P) domains that extend up to 6 nm from the capsid shell [14, 22]. This dimeric arrangement is a unique and defining structural feature, representing a clear departure from the trimeric spike organization observed in all other characterized nodaviruses.

Further structural analysis revealed surprising similarities between the MrNV capsid and members of the plant virus family Tombusviridae [14]. These shared characteristics include: (i) an extensive network of N-terminal arms that lace together asymmetric units on the capsid interior, (ii) stabilization of the capsid shell by pairs of Ca²⁺ ions within each asymmetric unit, and (iii) a protruding spike domain fold that is remarkably similar to that seen in tombusviruses [14]. These convergent structural features raise profound questions about the evolutionary history of MrNV and suggest a potential common ancestry or horizontal gene transfer event that has not yet been fully elucidated. The presence of these tombusvirus-like attributes, combined with the unique dimeric spikes, provides overwhelming evidence that MrNV does not fit neatly within the existing nodavirus taxonomy. The proposal to reclassify MrNV into a new genus, Gammanodavirus, is therefore not merely a semantic exercise but a necessary reflection of its distinct evolutionary lineage and structural biology [20, 22].

Genomic Organization and Molecular Architecture

The MrNV genome is bipartite, consisting of two single-stranded, positive-sense RNA molecules designated RNA1 and RNA2 [9, 20, 25]. This genomic organization is a hallmark of the Nodaviridae family.

RNA1 (Genomic Segment 1): This segment, approximately 3.2 kb in length, is the larger of the two and encodes a non-structural protein, the RNA-dependent RNA polymerase (RdRp) [5, 24, 28]. The RdRp is the central enzymatic machinery responsible for viral genome replication and transcription. Structural and functional characterization of the MrNV RdRp (MnRdRp) using AlphaFold2 modeling has revealed a three-dimensional architecture composed of three canonical subdomains, fingers, palm, and thumb, common to all viral polymerases [5]. Notably, the MnRdRp shares significant structural similarity with the RdRp of Bovine Viral Diarrhea Virus (BVDV), a member of the Flaviviridae family [5]. This structural homology has implications for antiviral drug development, as it suggests that inhibitors targeting flaviviral polymerases, such as Dasabuvir, may be repurposed to inhibit MrNV replication [5]. The RdRp also contains a methyltransferase domain, separated from the polymerase domain by a transmembrane region, which is involved in capping the viral RNA for efficient translation [5]. RNA1 also encodes a small subgenomic RNA that produces a B2 protein, a known suppressor of host RNA interference (RNAi), a critical antiviral defense mechanism in invertebrates [9, 28].

RNA2 (Genomic Segment 2): This segment, approximately 1.2 kb in length, encodes the single capsid protein (CP), which is the sole structural component of the virion [9, 15, 18, 21]. The CP is a 43 kDa protein that self-assembles into the icosahedral capsid. The CP is composed of two distinct domains: the N-terminal Shell (S) domain (residues 1-252) and the C-terminal Protruding (P) domain (residues 253-371) [2, 21]. The S-domain forms the continuous, icosahedral protein shell that encloses the viral genome. It is stabilized by calcium-binding domains (CBDs) that are critical for maintaining capsid integrity [2]. The P-domain, which forms the dimeric blade-like spikes on the virion surface, is the primary determinant of host cell tropism and attachment [2, 9, 21]. The P-domain is exclusively composed of β-sheet structures, with no α-helical content, a finding confirmed by both cryoEM and circular dichroism (CD) spectroscopy [21]. The dimeric interactions within the P-domain are maintained by a complex network of hydrogen bonds, hydrophobic interactions, and electrostatic forces, which have been characterized in detail using density functional theory (DFT) [16]. The P-domain can adopt two distinct conformations, parallel and X-shaped, which may be functionally relevant for host cell binding and entry [16].

The Role of the Extra Small Virus (XSV)

A persistent and enigmatic feature of WTD is its frequent association with a second, smaller virus known as the Extra Small Virus (XSV) [6, 11, 23, 26]. XSV is a non-enveloped, icosahedral virus approximately 15 nm in diameter, with a single-stranded RNA genome that is distinct from MrNV [26]. The relationship between MrNV and XSV has been a subject of intense investigation. Early studies suggested that XSV might be a satellite virus, dependent on MrNV for its replication. However, definitive experimental evidence using infectious clones has clarified this relationship. In experimental challenge studies, MrNV alone is sufficient to cause mortality and WTD lesions in M. rosenbergii post-larvae [11]. XSV alone, despite its ability to replicate, does not cause disease or mortality [11]. Co-infection with both viruses does not significantly increase mortality compared to MrNV infection alone [11]. These findings indicate that MrNV is the primary and sufficient etiological agent of WTD, while XSV appears to be a non-essential satellite or a co-infecting agent that may modulate the disease process in ways that are not yet fully understood. The detection of XSV in clinical samples, however, remains a useful diagnostic indicator for WTD outbreaks [23, 27].

Host Range, Tissue Tropism, and Pathogenesis

MrNV exhibits a relatively narrow host range, with the giant freshwater prawn M. rosenbergii being its primary and most economically significant host [8, 9]. However, experimental infections have demonstrated that the virus can infect other crustacean species, including the banana shrimp Penaeus merguiensis, which has been used as a model for infection studies [7]. The virus has a distinct tropism for muscular and nervous tissues. The primary target organs include the abdominal striated muscle, where it causes the characteristic whitish opacification due to extensive myonecrosis, and the gills [19, 29]. Histopathological examination reveals Zenker’s necrosis, myolysis, and massive infiltration of hemocytes in affected muscle tissues [6, 24]. The gills are a critical portal of entry, where MrNV virus-like particles (VLPs) have been shown to attach specifically to fucosylated N-glycans [19]. This glycan-dependent attachment is a key initial step in the infection process, and the interaction can be competitively inhibited by fucose-binding lectins [19]. The virus also targets the hematopoietic tissue (Hpt), which plays a dual role in both hemocyte production and immune defense [13]. Infection of the Hpt disrupts hemocyte homeostasis, contributing to the immunosuppression that characterizes severe disease.

The age-dependent susceptibility of M. rosenbergii to MrNV is a critical epidemiological feature. While larvae and post-larvae are highly susceptible, with mortality rates approaching 100%, adult prawns are largely resistant to clinical disease [9, 13]. This resistance is not due to a lack of viral entry, as adult prawns can harbor subclinical infections [6]. Instead, it is attributed to a more robust and rapidly deployed innate immune response in adults. Transcriptomic analyses have revealed that adult prawns mount a coordinated response involving the upregulation of humoral immune factors, such as anti-lipopolysaccharide factor (ALF), and the acceleration of hemocyte homeostasis via the Hpt [13]. In contrast, post-larvae exhibit a less effective immune response, with differential expression of key antiviral genes, including those encoding C-type lectins, prophenoloxidase, and Dicer, being insufficient to control viral replication [17]. This age-dependent immunity is a classic example of how host developmental stage dictates the outcome of viral infection.

Molecular Pathogenesis: Capsid Protein Structure and Infection Mechanism

The molecular pathogenesis of Macrobrachium rosenbergii nodavirus (MrNV) is fundamentally dictated by the structural biology of its capsid protein and the intricate cascade of host-cell interactions that facilitate viral entry, replication, and dissemination. As the causative agent of White Tail Disease (WTD), a condition recognized by the World Organisation for Animal Health (WOAH) as a significant threat to global crustacean aquaculture, MrNV exhibits a unique capsid architecture that distinguishes it from other members of the Nodaviridae family and underpins its remarkable virulence, particularly in larval and post-larval stages where mortality can reach 100% [1, 9, 20]. Understanding the capsid protein’s structure at atomic resolution is not merely an academic exercise; it is the cornerstone for deciphering the virus’s tropism, its mechanisms of immune evasion, and the rational design of intervention strategies, including vaccines, antiviral peptides, and diagnostic aptasensors.

The Atomic Architecture of the MrNV Capsid: A T=3 Icosahedron with Dimeric Spikes

High-resolution cryogenic electron microscopy (cryo-EM) has revolutionized our understanding of the MrNV virion, revealing a capsid that is structurally distinct from both insect-infecting alphanodaviruses and fish-infecting betanodaviruses. The MrNV capsid assembles into a non-enveloped, T=3 icosahedral particle approximately 30 nm in diameter, a size confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM) across multiple studies [3, 9, 14, 22]. The most striking feature of this capsid is the presence of prominent, dimeric blade-like spikes that project up to 6 nm from the underlying shell surface [14, 22]. This dimeric spike arrangement is a defining characteristic of MrNV and stands in stark contrast to the trimeric spikes observed in other nodaviruses, a structural divergence so significant that it has prompted the proposal to reclassify MrNV into a new genus, Gammanodavirus, within the Nodaviridae family [14, 20, 22].

The capsid protein (CP), encoded by the 1146-base-pair RNA2 segment, comprises 371 amino acid residues and is organized into two principal domains: the N-terminal Shell (S) domain (residues 1–252) and the C-terminal Protruding (P) domain (residues 253–371) [9, 21]. The S-domain forms the continuous, icosahedral shell that encapsulates the viral genome. Critically, the S-domain is stabilized by a network of calcium ions (Ca²⁺). Structural analysis at 3.3 Å resolution identified three pairs of Ca²⁺ ions per asymmetric unit, which are essential for maintaining the integrity of the capsid shell [14]. This calcium-dependent stability has profound implications for pathogenesis; chelation of calcium or exposure to high pH (8.5–10) can destabilize the capsid and inactivate the virus, a finding that aligns with chemical inactivation studies showing MrNV’s sensitivity to alkaline conditions [26]. The N-terminal arms of the S-domain form an extensive network of interactions that lace together asymmetric units on the interior surface of the capsid, a feature reminiscent of plant tombusviruses rather than animal nodaviruses [14]. This internal lacing likely contributes to the particle’s remarkable stability and its ability to package genomic RNA.

The P-domain, by contrast, is the primary mediator of host-cell interactions. Recombinant expression and characterization of the isolated P-domain in Escherichia coli confirmed that it forms stable dimers with a hydrodynamic diameter of approximately 6 nm, consistent with the blade-like spikes seen in the intact virion [21]. Circular dichroism (CD) spectroscopy revealed that the P-domain is composed almost exclusively of β-sheet structures (67.9%), with no α-helical content, a finding in perfect agreement with the cryo-EM density maps [21]. The dimeric interface of the P-domain is maintained by a complex network of non-covalent interactions. Quantum theory of atoms in molecules (QTAIM) and natural bond orbital (NBO) analyses, grounded in density functional theory (DFT), have identified key residue pairs, including Leu255–Lys287, Tyr257–Lys287, Met294–Cys328, and Asp295–Lys327, that stabilize the dimer through a combination of hydrogen bonds, charge-charge interactions, and hydrophobic forces [16]. These interactions are stronger in the parallel conformation of the P-domain dimer compared to the X-shaped conformation, suggesting a dynamic equilibrium that may be important for receptor binding or conformational changes during entry [16].

Host Cell Attachment: The Fucose-First Paradigm

The initial step in MrNV infection is the attachment of the P-domain spikes to specific receptor molecules on the surface of susceptible host cells. Seminal work has established that MrNV utilizes fucosylated glycans as primary attachment factors. Using MrNV virus-like particles (VLPs) as a surrogate for the native virion, researchers demonstrated robust binding to gill tissues and hemocytes of M. rosenbergii [19]. This binding was dramatically reduced by treatment with periodate (which oxidizes glycans) and PNGase F (which removes N-linked glycans), confirming the critical role of carbohydrate moieties [19]. Furthermore, the broad-spectrum fucose-binding lectin Aleuria Aurantia Lectin (AAL) effectively competed with MrNV-VLPs for binding to gill tissue sections and lysates, strongly implicating fucose as a key sugar residue [19].

Mass spectrometry analysis of gill glycoproteins revealed the presence of unique fucosylated LacdiNAc (GalNAcβ1-4GlcNAc)-extended N- and O-linked glycans. β-elimination experiments further indicated that MrNV-VLPs preferentially bind to N-glycans over O-glycans [19]. This specificity for fucosylated N-glycans explains the tropism of MrNV for gills and muscle tissues, which are rich in these glycan structures. The interaction is so specific that the carbohydrate-recognition domain (CRD) of the fucose-binding lectin CLEC17A (Prolectin) can be functionally grafted onto the MrNV capsid. Chimeric VLPs (CLEC17A/CRD-MrNV-VLPs), in which the native P-domain was replaced with the CLEC17A CRD, retained the ability to bind fucosylated glycoconjugates and, importantly, could competitively inhibit wild-type MrNV infection in Sf9 insect cells [2]. This elegant study not only confirms the fucose-binding mechanism but also demonstrates a novel antiviral strategy: using engineered, non-infectious VLPs to saturate cellular receptors and block viral entry.

The Sf9 insect cell line has proven to be an invaluable model for studying MrNV entry, as it is permissive to infection and expresses the necessary fucosylated glycans [2, 7, 30, 32]. In Sf9 cells, MrNV internalization is a rapid and energy-dependent process. Live-cell imaging and pharmacological inhibition studies have revealed that MrNV exploits both clathrin- and caveolae-mediated endocytosis pathways for cellular entry. Specifically, the entry of MrNV-VLPs into Sf9 cells was significantly inhibited by chlorpromazine (a clathrin inhibitor), genistein (a caveolae inhibitor), and methyl-β-cyclodextrin (which disrupts lipid rafts), but not by cytochalasin D (an actin polymerization inhibitor) [30]. This suggests a dual-entry mechanism, a redundancy that may enhance the virus’s ability to infect a wide range of cell types. The importance of the caveolae pathway was further highlighted by studies showing that MrNV infection could be halted by genistein and reactivated by okadaic acid, a phosphatase inhibitor that modulates caveolin-1 phosphorylation [32]. Following internalization, the virus traffics through the endosomal pathway. The presence of ammonium chloride (NH₄Cl), which raises endosomal pH, inhibited infection, indicating that acidification of endosomes is required for uncoating or penetration [30]. The capsid protein has also been shown to localize to the nucleus, and a putative nuclear localization signal (NLS) has been identified through deletion mutagenesis [30]. While MrNV is an RNA virus that replicates in the cytoplasm, the nuclear localization of the CP may be involved in modulating host cell transcription or facilitating genome replication.

Post-Entry Events: Replication, Assembly, and Egress

Once inside the host cell, the viral RNA1 segment, which encodes the RNA-dependent RNA polymerase (RdRp), is translated. The MrNV RdRp (MnRdRp) is a multi-domain enzyme containing a methyltransferase domain, a transmembrane region, and the core polymerase domain. Structural modeling using AlphaFold2 has revealed that MnRdRp adopts the canonical “fingers, palm, and thumb” architecture common to all RNA polymerases, with a conserved “priming helix” (residues 829–833) containing a tyrosine residue critical for de novo initiation of RNA synthesis [5]. The enzyme’s active site is electropositive, facilitating the binding of the negatively charged RNA template and incoming nucleotides. Key catalytic residues, including Asp599, Asp704, and Asp705, coordinate two Mn²⁺ ions that are essential for phosphodiester bond formation [5]. The structural similarity of MnRdRp to the RdRp of Bovine Viral Diarrhea Virus (BVDV), a member of the Flaviviridae, suggests that existing antiviral compounds, such as Dasabuvir, may be repurposed as inhibitors of MrNV replication [5].

The replication complex synthesizes a negative-sense RNA intermediate, which then serves as a template for the production of new genomic RNA1 and subgenomic RNA3. RNA3 encodes the B2 protein, a small, basic protein that functions as a suppressor of RNA interference (RNAi), a key antiviral defense mechanism in crustaceans [9, 20]. By inhibiting the host’s RNAi pathway, B2 ensures efficient viral replication and is a critical virulence factor. The capsid protein is translated from RNA2 and accumulates in the cytoplasm. The assembly of new virions occurs in the cytoplasm, where the capsid proteins self-assemble into icosahedral particles, packaging the genomic RNA1 and RNA2. The assembly process is remarkably robust; recombinant CP expressed in E. coli, insect cells, and even plant systems can spontaneously form VLPs that are morphologically and antigenically indistinguishable from native virions [3, 12, 18, 22]. This self-assembly property has been extensively exploited for vaccine development and nanocarrier applications. The release of progeny virions is thought to occur through cell lysis, as MrNV infection induces pronounced cytopathic effects (CPE), including cytoplasmic swelling, cell clumping, and ultimately, cell death [7, 25, 32]. In infected M. rosenbergii, this leads to the characteristic whitish discoloration of the abdominal muscle, which is a result of severe myonecrosis, Zenker’s necrosis, and myolysis [6, 24, 27].

Molecular Determinants of Virulence and Host Specificity

The structural and functional data explain the stark age-dependent susceptibility of M. rosenbergii to MrNV. While post-larvae suffer near-total mortality, adult prawns are largely resistant to disease [9, 13]. This resistance is not due to a lack of receptors, as adult tissues still bind MrNV, but rather to a robust and rapid immune response orchestrated by the hematopoietic tissue (Hpt). Transcriptomic analysis of MrNV-infected adult prawn Hpt revealed the upregulation of genes involved in hemocyte hematopoiesis, such as crustacean hematopoietic factor (CHF) and cell growth-regulating zinc finger protein (Lyar), alongside immune effectors like anti-lipopolysaccharide factor (ALF) [13]. This dual role of the Hpt, producing new hemocytes to replace those lost to infection while simultaneously mounting a humoral immune response, is a key factor in adult resistance. In contrast, post-larvae lack a fully developed Hpt and a mature immune system, rendering them highly vulnerable [13, 17].

The capsid protein itself is a major determinant of virulence. Codon deoptimization of the RNA2 segment, which introduced 125 synonymous mutations without altering the amino acid sequence, resulted in a significantly attenuated virus. Sf9 cells transfected with the deoptimized RNA2 showed minimal CPE compared to the wild-type, despite comparable levels of protein expression [25]. This suggests that the speed and efficiency of capsid protein translation, governed by codon usage, directly influence viral fitness and pathogenicity. Furthermore, the P-domain is not only essential for attachment but also for maintaining the structural integrity required for infection. Truncation of 27 amino acids from the C-terminus of the P-domain, or removal of the entire P-domain (yielding smooth V250-MrNV-VLPs), abrogates the ability of the VLPs to bind to Sf9 cells and infect them, highlighting the absolute requirement of the spike domain for infectivity [2]. The specific residues within the P-domain that contact the fucosylated receptor are still being elucidated, but peptide inhibition studies have identified two 12-mer peptides (HTKQIPRHIYSA and VSRHQSWHPHDL) that bind to the MrNV VLP with high affinity (Kd of 92.4 nM and 12.7 nM, respectively) and inhibit VLP entry into Sf9 cells with an IC50 of 4.9 µM when used in combination [31]. These peptides likely mimic the receptor-binding site on the host cell or block a critical conformational change in the P-domain required for entry.

In summary, the molecular pathogenesis of MrNV is a story of structural specialization. The unique dimeric spike architecture of the capsid, stabilized by calcium and driven by β-sheet interactions, is exquisitely adapted to recognize and bind fucosylated N-glycans on the surface of susceptible crustacean cells. This binding triggers a clathrin/caveolae-mediated endocytic entry, followed by RdRp-driven replication and B2-mediated suppression of host RNAi. The age-dependent resistance in adult prawns is a testament to the power of the crustacean innate immune system, while the devastating susceptibility of post-larvae underscores the critical window of vulnerability that the virus exploits. This detailed molecular understanding provides a rational framework for developing targeted interventions, from fucose-mimicking inhibitors and entry-blocking peptides to structurally-informed vaccines and codon-deoptimized live-attenuated strains.

Epidemiology of White Tail Disease and Economic Impact in Aquaculture

The global expansion of Macrobrachium rosenbergii aquaculture, while contributing significantly to food security and rural livelihoods in many developing nations, has been severely hampered by the emergence of White Tail Disease (WTD). The etiological agent, Macrobrachium rosenbergii nodavirus (MrNV), has established itself as one of the most formidable pathogens in freshwater prawn cultivation, presenting a complex epidemiological profile that is inextricably linked to substantial and often devastating economic consequences. Understanding the multifaceted nature of WTD epidemiology, from its geographic dissemination and host range to the nuanced interplay of age-related susceptibility and co-infections, is paramount for devising effective control strategies and mitigating the profound financial losses incurred by the global aquaculture industry. The World Organisation for Animal Health (WOAH) recognizes the significant impact of aquatic animal diseases, and MrNV exemplifies a pathogen that threatens the sustainability of a critical food production sector, particularly in Southeast Asia and other regions where the giant freshwater prawn is a cornerstone of aquaculture economies.

Geographic Distribution and Global Prevalence

Since its initial identification in the late 1990s, MrNV has demonstrated a remarkable capacity for transboundary spread, mirroring the global trade in live aquatic animals and broodstock. The virus has been documented across a wide swath of Asia, including major producing nations such as China, India, Thailand, Indonesia, Taiwan, and Malaysia [9, 20, 24]. The first definitive report of WTD in Indonesia, for instance, detailed an outbreak in a hatchery in Yogyakarta, where clinical signs of whitish tail muscle in post-larvae were confirmed by RT-PCR and electron microscopy, revealing icosahedral virions of approximately 28 nm [24]. This event underscored the vulnerability of emerging aquaculture regions to the pathogen, which likely entered via infected stock. The geographical reach of MrNV is not static; recent surveillance efforts have extended the known distribution to non-endemic areas. A pivotal study conducted in the Republic of Korea in 2021 detected MrNV in both adult and post-larval M. rosenbergii from three different farms in Gyeongsangnam-do, marking the first report of the virus in the country [6]. Critically, these Korean isolates were found in apparently healthy prawns exhibiting no gross signs of WTD, yet histopathological examination revealed underlying Zenker’s necrosis and myolysis in the abdominal striated muscle [6]. This finding is epidemiologically significant, as it confirms the existence of subclinical carriers that can act as reservoirs for viral dissemination, complicating disease surveillance and biosecurity efforts. Furthermore, the detection of a related but distinct nodavirus, Covert Mortality Nodavirus (CMNV), in farmed M. rosenbergii in Jiangsu Province, China, at a prevalence of 61.9% (70/113 samples), expands the known host range of these pathogens and suggests that the nodaviral landscape in prawn aquaculture is more complex than previously understood [29].

Host Range and Species Susceptibility

While M. rosenbergii remains the primary and most economically significant host, the host range of MrNV is broader than originally presumed. The virus has been shown to infect other crustacean species, including various penaeid shrimp, although the clinical outcomes and mortality rates vary considerably. For instance, experimental infections using Penaeus merguiensis as a model demonstrated that MrNV produced from Drosophila S2 cells could induce the characteristic whitish abdominal muscle sign and a significant reduction in hemocyte count within 24 hours post-infection [7]. This demonstrates the potential for MrNV to bridge the gap between palaemonid prawns and penaeid shrimp, raising concerns about cross-species transmission in polyculture systems or shared water bodies. Beyond crustaceans, the virus's capsid protein has been exploited for its remarkable ability to self-assemble into virus-like particles (VLPs) that can infect and replicate in insect cell lines, such as Spodoptera frugiperda (Sf9) cells [2, 11, 30, 32]. This tropism for insect cells, facilitated by binding to fucosylated glycans [2, 19], not only provides a critical in vitro model for studying viral pathogenesis but also hints at a potential broader ecological host range that warrants further investigation.

Age-Related Susceptibility and Mortality Dynamics

One of the most defining epidemiological features of WTD is its pronounced age-dependent susceptibility. The disease exerts its most catastrophic effects on larval and post-larval stages, where mortality rates can approach 100% within 4 to 5 days of clinical onset [1, 4, 9, 17, 22, 26]. This acute phase is characterized by a rapid onset of whitish opacity in the abdominal muscle, lethargy, and mass mortality, leading to the complete loss of entire hatchery cohorts [24, 27]. The molecular underpinnings of this susceptibility are multifaceted. Transcriptomic analysis of MrNV-infected post-larvae revealed a massive dysregulation of the host immune response, with 2,413 significantly up-regulated and 3,125 down-regulated genes, including key players in innate antiviral immunity such as C-type lectins, prophenol oxidase, caspases, and dicer [17]. This suggests that the post-larval stage may be immunologically immature or overwhelmed by the rapid replication of the virus.

Conversely, adult M. rosenbergii are largely resistant to lethal MrNV infection, often serving as asymptomatic carriers [6, 9, 13]. This resistance is not absolute but is a consequence of a more robust and rapidly mobilized immune system. A seminal study elucidated the dual role of the hematopoietic tissue (Hpt) in adult prawns as both a source of hemocyte replenishment and a frontline defensive organ [13]. Upon MrNV challenge, the Hpt in adults orchestrates a rapid upregulation of immune-related genes and cell growth-regulatory factors like crustacean hematopoietic factor (CHF) and Lyar, leading to accelerated hemocyte homeostasis and a surge in humoral immune factors such as anti-lipopolysaccharide factor (ALF) [13]. This ability to mount a swift and effective innate immune response, rather than a complete absence of infection, is what protects adults and allows them to transmit the virus vertically or horizontally without displaying overt disease, thus perpetuating the infection cycle on farms.

The Role of the Extra Small Virus (XSV) in Disease Epidemiology

A significant epidemiological nuance is the frequent co-infection of MrNV with the Extra Small Virus (XSV), a satellite-like virus that is almost always found in association with MrNV in WTD outbreaks [6, 23, 27]. For years, the relative contribution of each virus to pathogenicity remained a subject of debate. Definitive experimental evidence resolved this question when infectious clones of both viruses were constructed and used in challenge tests. It was conclusively demonstrated that MrNV alone is sufficient to cause mortality and WTD lesions in M. rosenbergii post-larvae, while XSV alone, despite replicating, fails to induce any clinical disease or death [11]. This establishes MrNV as the primary causative agent. The epidemiological role of XSV, therefore, is likely that of a dependent or modulating co-factor. Its presence may enhance the severity of MrNV infection or affect viral transmission dynamics, a hypothesis supported by its consistent detection in many field outbreaks. The variable detection rates of XSV, for instance, a study in Indonesia found 13/15 samples positive for MrNV but only 5/15 positive for XSV [27], suggest that XSV is not an absolute requirement for WTD epizootics but may contribute to the overall disease burden in certain ecological or geographical contexts.

Economic Impact on Aquaculture Production

The economic consequences of WTD are stark and multi-layered, extending from direct mortality losses to the costs associated with surveillance, biosecurity, and lost market opportunities. The hallmark of WTD in hatcheries is the near-total mortality of larval and post-larval populations. With mortality rates routinely exceeding 80-100% in infected nursery tanks, the direct loss of seed stock is catastrophic [1, 4, 9]. For a single hatchery, an outbreak can mean the loss of millions of PLs, representing a significant investment in broodstock maintenance, hatchery operations, labor, and feed. This has a cascading effect on the entire value chain. Grow-out farmers who rely on a consistent supply of healthy PLs face shortages, leading to reduced stocking densities or delays in production cycles, which in turn diminishes overall harvest volumes and farmer income. The economic hit is particularly severe for smallholder farmers, who often lack the capital reserves to absorb such losses, threatening their livelihoods and food security [14, 22].

The economic impact extends beyond direct mortality. The presence of subclinical infections in broodstock [6, 20] undermines the integrity of breeding programs and can lead to vertical transmission, perpetuating the disease cycle and undermining long-term productivity. Furthermore, managing WTD necessitates substantial investment in biosecurity measures, including rigorous disinfection protocols. Chemical and physical treatments, such as UV irradiation, high pH (8.5-10), and disinfectants like sodium hypochlorite and iodine at specific concentrations, are known to inactivate MrNV, but their routine application adds operational costs [26]. The costs associated with diagnostic screening, using methods like RT-PCR, qRT-PCR, NASBA, or LAMP-based assays, to ensure that stock is virus-free before transfer or sale are another significant economic factor [23, 33, 34]. On a macro-economic scale, WTD restricts the growth and sustainability of the entire M. rosenbergii farming sector in affected regions. The FAO has highlighted that such viral diseases are a major constraint on the expansion of crustacean aquaculture, which is a critical source of animal protein and employment in many developing economies. The ongoing threat of WTD discourages investment, limits production capacity, and can erode consumer and market confidence in the product.

Surveillance, Detection, and Economic Mitigation

The economic burden of WTD is amplified by challenges in early detection and the lack of effective therapeutic agents. Since adult carriers can appear healthy, routine surveillance using sensitive diagnostic tools is essential but can be costly and requires technical expertise. The gold standard for confirmation remains molecular detection, such as reverse transcription-PCR (RT-PCR) and quantitative RT-PCR (qRT-PCR). However, these methods require sophisticated laboratory equipment and trained personnel, making them less accessible for on-site, rapid diagnosis in remote hatcheries. This gap has driven the development of more field-deployable technologies. The combination of nucleic acid sequence-based amplification (NASBA) with a lateral flow dipstick (LFD) offers a highly sensitive alternative, capable of detecting as little as 1.0 fg of total RNA from MrNV-infected prawns, which is 10,000 times more sensitive than conventional RT-PCR [33]. Similarly, reverse transcription loop-mediated isothermal amplification (RT-LAMP) combined with LFD provides a rapid, sensitive, and specific assay that can be performed at a constant temperature (61°C) with minimal instrumentation, detecting as low as 1.0 pg of total RNA [23]. Most recently, the development of an antibody-based lateral flow assay (LFA) has achieved a limit of detection of 10⁴ virus particles per nanogram of total RNA, yielding results within 20 minutes, with 100% sensitivity and 90% specificity when validated against qRT-PCR in field samples [34]. The ability to rapidly detect MrNV on-site, particularly at the PL stage, allows farmers to make immediate management decisions to cull infected stock, quarantine potentially exposed cohorts, and implement enhanced disinfection before the virus can spread throughout the facility [34]. The economic value of such rapid diagnostic tests cannot be overstated; by enabling a "test and remove" strategy, they can prevent the catastrophic losses associated with a full-blown outbreak. From a global food security and animal health perspective, the integration of such affordable, rapid diagnostics into routine hatchery management is a critical step in reducing the staggering economic impact of White Tail Disease and securing the future of M. rosenbergii aquaculture.

Host–Virus Interactions and Immune Evasion Strategies

The pathogenesis of Macrobrachium rosenbergii nodavirus (MrNV) is a paradigm of molecular co-evolution, wherein the virus has honed sophisticated strategies to exploit host cellular machinery while simultaneously subverting the innate immune defenses of its crustacean host. Unlike vertebrates, crustaceans rely exclusively on an innate immune system that lacks the classical adaptive memory conferred by immunoglobulins and T-cell receptors. Consequently, MrNV faces a unique selective pressure: it must evade or counteract robust, germline-encoded antiviral responses such as the RNA interference (RNAi) pathway, the prophenoloxidase (proPO) cascade, and phagocytic clearance by hemocytes. The interplay between MrNV and the host is a dynamic arms race, characterized by specific receptor-mediated entry, intracellular trafficking that avoids degradative pathways, and active suppression of host antiviral gene expression. This section provides an exhaustive analysis of the molecular and cellular mechanisms governing MrNV–host interactions and the strategies the virus employs to establish a productive infection, drawing upon structural biology, transcriptomics, and functional studies.

Molecular Basis of Cellular Entry: Glycan Receptors and Endocytic Pathways

Initial viral attachment is the critical determinant of host tropism and tissue specificity. For MrNV, the entry process is meticulously choreographed, beginning with the recognition of specific glycan receptors on the surface of susceptible cells. The viral capsid, assembled from 180 copies of the capsid protein (CP), presents a T=3 icosahedral architecture characterized by distinctive dimeric blade-like protrusions formed by the protruding (P) domain [14, 22]. These spikes are not merely structural embellishments; they are the primary mediators of host cell binding. Structural studies have demonstrated that the P-domain, which forms stable dimers in solution, contains the receptor-binding interface [21]. The critical role of the P-domain was elegantly demonstrated by studies showing that truncation of 27 amino acids from its C-terminus severely abrogates the ability of MrNV virus-like particles (VLPs) to bind to susceptible Sf9 insect cells and white tail disease (WTD)-associated tissues [2].

The molecular identity of the host receptor has been a subject of intensive investigation. Compelling evidence points to fucosylated glycans as the essential attachment molecules. MrNV-VLPs bind with high affinity to gill tissue sections and lysates, a tropism that is profoundly inhibited by treatment with periodate (which oxidizes glycans) and PNGase F (which removes N-linked glycans) [19]. The binding is exquisitely specific: the broad fucose-binding lectin Aleuria aurantia lectin (AAL) effectively blocks MrNV-VLP attachment. Detailed mass spectrometric analysis of gill glycoproteins has identified unique fucosylated LacdiNAc-extended N- and O-linked glycans, with MrNV showing a distinct preference for N-glycans over O-glycans [19]. This requirement for fucosylation is corroborated by studies in Sf9 insect cells, where MrNV infection is dependent on glycans bearing the sequence HexNAc(Fuc)HexNAc-R or Fuc-LacdiNAc [2]. The biological relevance of this interaction is further underscored by the design of a chimeric VLP (CLEC17A/CRD-MrNV-VLPs) that replaces the native P-domain with a fucose-binding carbohydrate-recognition domain. This chimeric particle not only binds fucosylated glycoconjugates but also significantly reduces MrNV infection in Sf9 cells, likely by competing for receptor occupancy [2].

Following receptor engagement, MrNV must negotiate the plasma membrane to gain access to the cytoplasm. The virus does not rely on a single, passive entry route but instead exploits active endocytic pathways. Fluorescently labeled MrNV-CP VLPs, when tracked in Sf9 cells, undergo internalization and eventually traffic to the nucleus [30]. The journey is sensitive to specific pharmacological inhibitors. Chlorpromazine (CPZ), an inhibitor of clathrin-mediated endocytosis, and methyl-β-cyclodextrin, which disrupts caveolae/lipid rafts, both severely inhibit VLP entry. Conversely, cytochalasin D, which disrupts actin filaments and macrophocytosis, has no effect [30]. This indicates a synergistic reliance on both clathrin- and caveolae-mediated endocytosis for successful internalization. The importance of the caveolin pathway is further validated by studies showing that MrNV infection in Sf9 cells can be halted by genistein (a tyrosine kinase inhibitor that blocks caveolae formation) and reactivated by okadaic acid [32]. Furthermore, host factors such as caveolin-1 have been identified as key binding targets for the virus during this process [9]. This dual-pathway strategy may allow MrNV to infect a broader range of cell types or circumvent host-induced blocks on a single entry route.

Intracellular Trafficking, Replication, and Nuclear Localization

Once internalized within endocytic vesicles, MrNV must escape degradation in the lysosome and establish its replication complex. The capsid itself contains an intrinsic nuclear localization signal (NLS), which is critical for the journey of the viral genome to the nucleus. Deletion mutagenesis studies have identified a functional classical NLS within the MrNV CP, and the VLP cargo eventually arrives at the nuclear membrane [30]. The functional significance of nuclear localization remains an area of active research, but given that MrNV is a positive-sense RNA virus that replicates entirely in the cytoplasm, this nuclear association may be linked to subverting host transcription or accessing nuclear factors for replication or assembly.

The replication of the MrNV genome is dependent on its RNA-dependent RNA polymerase (RdRp), encoded by RNA1. The MrNV RdRp shares structural and functional hallmarks with polymerases of the Flaviviridae family, despite the taxonomic distance [5]. The AlphaFold2-predicted structure reveals the canonical fingers, palm, and thumb subdomains, with a conserved 'priming helix' containing a tyrosine residue (Tyr 829-833) likely critical for de novo initiation of RNA synthesis [5]. The active site is characterized by metal-binding residues (Asp599, Asp704, Asp705) that coordinate Mn2+ ions, essential for catalysis [5]. This structural similarity to well-characterized viral polymerases opens the door for potential therapeutic repurposing. Computational docking studies have identified Dasabuvir, a known inhibitor of the hepatitis C virus polymerase, as a potential inhibitor of the MrNV RdRp [5]. This suggests a conserved druggable pocket that could be exploited for antiviral development.

Coincident with genome replication, MrNV expresses a small, non-structural B2 protein. This protein is a potent suppressor of RNA interference (RNAi), the primary antiviral defense mechanism in invertebrates. By sequestering double-stranded RNA (dsRNA) and short interfering RNAs (siRNAs), the B2 protein prevents their loading into the RNA-induced silencing complex (RISC), thereby neutralizing the host's ability to degrade viral RNA [9, 20]. This is a critical immune evasion strategy; without B2, the host RNAi machinery would rapidly clear the viral infection. The success of MrNV infection is therefore intrinsically linked to its capacity to dismantle this frontline defense.

Host Transcriptomic Landscape and the Battle for Hemocyte Homeostasis

The host response to MrNV infection is a complex and dynamic transcriptional program that varies dramatically with developmental stage and tissue type. The most striking dichotomy is the stark difference in susceptibility between post-larvae (PL) and adult prawns. While MrNV causes up to 100% mortality in PL, adult M. rosenbergii are largely resistant and can carry the virus asymptomatically [6, 13]. This resistance is not due to a lack of viral entry but rather a robust and rapid immune response mounted by the adult hematopoietic system.

Transcriptomic analysis of MrNV-infected PL reveals a massive and dysregulated immune response. Differential expression analysis of PL transcriptomes shows thousands of genes significantly altered upon infection, including 2,413 up-regulated and 3,125 down-regulated unigenes [17]. While some immune genes like C-type lectins, prophenoloxidase, and caspases are activated, the overall picture is one of collapse, possibly due to the overwhelming viral load and the immature state of the PL immune system [17].

In stark contrast, the adult prawn's resistance is orchestrated by the hematopoietic tissue (Hpt). The Hpt serves dual roles: it is the site of hemocyte production (hematopoiesis) and a central hub for immune signaling. Upon MrNV challenge in adults, the Hpt rapidly upregulates genes involved in hemocyte proliferation, such as crustacean hematopoietic factor (CHF) and cell growth-regulating zinc finger protein (Lyar) [13]. Concurrently, there is a significant upregulation of humoral immune factors, including anti-lipopolysaccharide factor (ALF) and other antimicrobial peptides. This response peaks as early as 6 hours post-infection, demonstrating a rapid and efficient reaction that controls viral replication before it can become systemic [13]. The hemocyte population itself is dynamic; in an in vivo model using Penaeus merguiensis, total hemocyte counts drop sharply within 6-24 hours post-infection (likely due to migration to infection sites or viral-induced apoptosis) but recover by 48 hours, suggesting a strong regenerative capacity [7]. This efficient deployment of hemocytes and immune effectors is the cornerstone of adult resistance.

Subversion of Cellular Stress and Apoptotic Pathways

Beyond RNAi suppression, MrNV manipulates other critical host pathways to favor its replication. The infection induces a significant upregulation of heat shock protein 70 (HSP70) [7]. HSP70 is a molecular chaperone involved in protein folding and stress responses. While its upregulation is a canonical host stress response, many viruses hijack HSP70 to stabilize viral proteins, assist in capsid assembly, or modulate apoptosis. Its role in MrNV pathogenesis warrants further investigation but likely contributes to the creation of a favorable cellular environment for viral replication.

Conversely, the host attempts to limit viral spread through apoptosis, a programmed cell death mechanism that can eliminate infected cells. MrNV infection triggers the expression of caspases, the key executioners of apoptosis [17]. The virus, however, appears to have mechanisms to delay or modulate this process to ensure sufficient time for viral progeny production. The B2 protein, in addition to its RNAi suppressor activity, may also possess anti-apoptotic functions, a common multifunctional trait among small viral proteins.

Co-Infection Dynamics with Extra Small Virus (XSV) and Latent Infections

A further layer of complexity in MrNV pathogenesis is its frequent association with the extra small virus (XSV), a satellite virus that is dependent on MrNV for its replication. The role of XSV in the etiology of WTD has been controversial. Elegant studies using infectious clones of both viruses have definitively resolved this question: MrNV alone is sufficient to cause mortality and WTD lesions in challenge experiments [11]. XSV alone is non-pathogenic, even though it replicates. However, co-infection may modulate the severity of the disease, although the precise molecular interplay between the two viruses remains poorly understood [9, 11]. The presence of XSV may alter host immune recognition or compete for cellular resources, thereby influencing the outcome of the primary MrNV infection.

Finally, a significant concern for aquaculture biosecurity is the existence of asymptomatic carriers. MrNV has been detected in apparently healthy adult and PL prawns from farms in Korea and other regions, where histopathological lesions (Zenker's necrosis and myolysis) were present but gross signs of WTD were absent [6]. This indicates that MrNV can establish persistent, subclinical infections. This latency allows the virus to evade detection and be unknowingly transmitted through stock movements, serving as a constant reservoir for future outbreaks. The molecular mechanisms governing the switch from latent to lytic infection in MrNV are unknown but likely involve environmental stressors or a decline in host immune status. The detection of covert mortality nodavirus (CMNV), a related nodavirus, in the gonads of M. rosenbergii also raises the alarming possibility of vertical transmission from broodstock to offspring, a mechanism that would allow the virus to persist across generations [29]. This highlights the critical need for sensitive surveillance of broodstock populations, as recommended by the World Organisation for Animal Health (WOAH) standards for aquatic animal health, to prevent the introduction of such pathogens into hatchery systems. The Food and Agriculture Organization (FAO) has also emphasized the economic threat WTD poses to food security in developing nations, underscoring the need for a deeper understanding of these host–virus dynamics to inform strategic intervention.

Diagnostic Approaches: From Genome-Based Methods to Aptamer Sensors

The accurate and timely detection of Macrobrachium rosenbergii nodavirus (MrNV) is paramount for mitigating the catastrophic economic losses inflicted by white tail disease (WTD) in global freshwater prawn aquaculture. With mortality rates in larvae and post-larvae frequently reaching 100% [1, 9, 20], the imperative for diagnostic platforms that are not only sensitive and specific but also rapid, cost-effective, and deployable in field settings has driven a dynamic evolution in detection methodologies. This section provides a comprehensive, authoritative examination of the diagnostic landscape for MrNV, tracing the trajectory from foundational genome-based molecular techniques to the cutting-edge frontier of aptamer-based biosensors. The analysis integrates structural biology, epidemiological context, and mechanistic insights to evaluate the strengths, limitations, and operational niches of each approach, with a focus on their practical utility for aquaculture biosecurity and outbreak management.

Genome-Based Detection Methods: The Molecular Foundation

The cornerstone of MrNV diagnostics has historically been the detection of viral nucleic acids, leveraging the unique genetic signatures of its bipartite, positive-sense ssRNA genome. The genome comprises RNA1, which encodes the RNA-dependent RNA polymerase (RdRp), and RNA2, which encodes the capsid protein (CP) [5, 20, 24]. Standard reverse transcription-polymerase chain reaction (RT-PCR) has been a mainstay for confirming MrNV infection, primarily targeting conserved regions of the CP gene or the RdRp gene [24, 27, 28]. This approach, validated in numerous geographical isolates from China, India, Indonesia, and Korea, provides high specificity and allows for downstream amplicon sequencing, which is critical for phylogenetic analyses and tracking viral evolution [6, 24]. For instance, epidemiological studies in Korea successfully employed RT-PCR to detect MrNV in apparently healthy adult and post-larval prawns, revealing subclinical infections that underscore the utility of molecular screening for surveillance [6]. Similarly, the Indian isolate was characterized through cloning and sequencing of RT-PCR products of the RdRp, B2, and capsid genes, providing foundational sequence data for subsequent diagnostic developments [28]. The quantitative variant, real-time RT-PCR (qRT-PCR), has emerged as the gold standard reference method, offering the capacity to quantify viral load and assess infection severity. Studies validating lateral flow assays (LFAs) against MrNV have consistently used qRT-PCR as the benchmark, achieving high correlation and a Cohen's kappa coefficient of 0.936, indicating ‘good agreement’ between the rapid test and the molecular gold standard [34]. Furthermore, TaqMan RT-qPCR has been instrumental in detecting covert mortality nodavirus (CMNV), a related nodavirus, in M. rosenbergii, demonstrating the technique's versatility for identifying novel viral threats within the same host species [29].

Despite their robustness, conventional genome-based methods present significant logistical challenges. They require sophisticated thermocycling equipment, costly reagents, highly trained personnel, and dedicated laboratory infrastructure, resources often scarce in remote hatcheries and farming communities where rapid on-site intervention is most critical [1, 4]. The time-to-result, typically several hours to a full day, can be a critical bottleneck during an active outbreak requiring immediate containment measures. This has driven the search for alternative amplification strategies that maintain molecular-level sensitivity while circumventing the need for complex instrumentation.

Isothermal Amplification Strategies: Bridging the Gap to Field Deployability

A crucial advancement towards field-deployable molecular diagnostics is the adoption of isothermal amplification technologies, which operate at a constant temperature, eliminating the need for a thermal cycler. Two primary methodologies have been adapted for MrNV detection: reverse transcription loop-mediated isothermal amplification (RT-LAMP) and nucleic acid sequence-based amplification (NASBA).

The RT-LAMP assay, often coupled with a lateral flow dipstick (LFD) for visual readout, represents a paradigm shift in point-of-care (POC) molecular testing. For MrNV and the co-infecting extra small virus (XSV), a duplex RT-LAMP-LFD assay was developed targeting six conserved regions within the capsid protein genes (CP43 for MrNV and CP17 for XSV) [23]. This assay operates at a constant 61°C for 60 minutes, followed by a rapid 5-minute hybridization with a FITC-labeled probe, with results visualized on an LFD. This system demonstrated a sensitivity approximately 100-fold higher than conventional RT-PCR and could detect as little as 1.0 pg of total RNA from infected M. rosenbergii tissue [23]. The simplicity, speed, and minimal instrumentation requirements make this an exceptionally practical tool for hatchery screening.

An even more sensitive isothermal approach is the NASBA-LFD combination. NASBA is specifically designed for RNA targets, utilizing a three-enzyme system (reverse transcriptase, RNase H, and T7 RNA polymerase) to amplify RNA under isothermal conditions (41°C) [33]. An assay targeting the MrNV capsid protein gene achieved an extraordinary sensitivity of 1.0 femtogram (fg) of total RNA from infected prawns [33]. This represents a 10,000-fold improvement in sensitivity over conventional RT-PCR, a leap in detection capability that is critical for identifying very low viral loads during early infection or in carrier animals. The specificity of the NASBA-LFD assay was validated by showing no cross-reactivity with other shrimp viral pathogens, including white spot syndrome virus (WSSV) and infectious hypodermal and hematopoietic necrosis virus (IHHNV) [33]. The combined attributes of extreme sensitivity, isothermal operation, a visual LFD readout, and a total assay time of under two hours position NASBA-LFD as a potential game-changer for early outbreak detection, a factor recognized by organizations like the World Organisation for Animal Health (WOAH) as vital for containing transboundary aquatic animal diseases.

Protein-Based Detection and Immunoassays

Parallel to nucleic acid tests, protein-based detection methods target the structural components of the virion, primarily the abundant capsid protein (CP). The MrNV capsid, a T=3 icosahedral structure with unique dimeric blade-like spikes, is composed of 180 copies of the CP, making it an excellent target for antibody-based recognition [9, 14, 22]. The most prominent development in this arena is the lateral flow assay (LFA), an immunochromatographic strip test designed for rapid, on-site detection. An optimized LFA for MrNV, utilizing gold nanoparticles (GNPs) conjugated to specific antibodies against the viral capsid, demonstrated a limit of detection (LOD) of 10⁴ virus particles per nanogram of total RNA, with a result time of just 20 minutes [34]. In a comparative validation against qRT-PCR using 80 field samples from hatcheries and nurseries, this LFA achieved a diagnostic sensitivity of 100% and specificity of 90%, confirming its reliability as a screening tool [34]. The LFA is inherently more practical than molecular methods for non-specialists, requiring only a simple sample homogenization and a dipstick. However, its sensitivity is several orders of magnitude lower than qRT-PCR or NASBA, potentially missing early-stage infections with low viral loads.

Aptamer-Based Diagnostic Platforms: The Synthetic Antibody Revolution

A critical gap in MrNV diagnostics remains the trade-off between the high sensitivity of molecular assays and the operational simplicity of immunoassays. Furthermore, antibody production is time-consuming, costly, and subject to batch-to-batch variability. Aptamers, short, single-stranded DNA or RNA oligonucleotides that fold into unique three-dimensional structures capable of binding target molecules with high affinity and specificity, offer a powerful synthetic alternative. Selected through an iterative in vitro process called Systematic Evolution of Ligands by Exponential Enrichment (SELEX), they are often termed "chemical antibodies" [4].

The application of aptamers to MrNV diagnostics began with the selection of a novel ssDNA aptamer, APT-MrNV-CP-1, specifically targeting the recombinant MrNV capsid protein [4]. Using magnetic-capture SELEX coupled with next-generation sequencing (NGS), this aptamer was enriched across multiple selection cycles, with its prevalence increasing from 1.76% in cycle 4 to 12.42% in cycle 12 [4]. The utility of this aptamer as a capture agent was demonstrated by conjugating it to citrate-capped gold nanoparticles (AuNPs) to create an AuNP-based aptasensor. In this colorimetric platform, the presence of the MrNV capsid protein induces aptamer-mediated agglomeration of the AuNPs, resulting in a visible color change from red to blue or grey. This aptasensor showed a detection limit of 62.5 nM of MrNV capsid protein, representing a simple, rapid, and instrument-free method [4].

A landmark advancement in aptamer performance was achieved through rational truncation of the parent aptamer. The 5' and 3' primer-binding domains, essential for SELEX amplification but often unnecessary for target binding, were removed, resulting in a truncated aptamer with a dramatically improved dissociation constant (Kd) from 347 nM to 30.1 nM, an 11.5-fold enhancement in binding affinity [1]. This truncation strategy is mechanistically significant, as the removal of the primer overhang likely eliminates non-specific electrostatic interactions and steric hindrances, allowing the remaining core sequence to adopt a more stable, high-affinity conformation. The improved affinity translated directly to superior analytical performance. The calculated limit of detection (LOD) for the truncated aptamer decreased from 5.64 nM to 1.7 nM, while the limit of quantification (LOQ) decreased from 17.1 nM to 5.16 nM [1]. When deployed in both an enzyme-linked aptamer assay (ELAA) and a gold nanoparticle aptasensor, the truncated aptamer demonstrated consistent results with MrNV-infected prawn tissue lysates, albeit with a critical caveat: optimal performance required a precise input of 0.5 µg of total protein lysate, highlighting that excessive host protein can interfere with the aptamer-viral protein interaction [1].

This high-binding, truncated aptamer is a prime candidate for integration into a practical, user-friendly diagnostic kit, such as an aptamer-based lateral flow assay (Aptamer-LFA). Unlike antibody-based LFAs, an Aptamer-LFA offers the advantages of a synthetic, animal-free production process, high chemical stability, and the potential for lower manufacturing costs [1]. The ultimate vision is a lateral flow test strip where the truncated aptamer serves as both the capture and detection probe, enabling a one-step, dipstick-style test that provides a clear visual result within minutes, requiring no sophisticated equipment or interpretation [1]. This would be an ideal solution for rapid, mass screening of post-larvae in hatcheries, directly addressing the needs of farmers and extension workers in resource-limited settings.

In summary, the diagnostic ecosystem for MrNV has expanded from a reliance on centralized laboratory-based PCR to a diversified toolkit encompassing highly sensitive isothermal amplification (NASBA-LFD, RT-LAMP-LFD), field-ready immunoassays (LFA), and the emerging technology of aptamer sensors. While isothermal methods currently offer the greatest sensitivity for field applications, aptamer-based sensors represent the most promising path towards achieving a balance of high sensitivity, extreme operational simplicity, and low cost, particularly through the development of the next-generation Aptamer-LFA. The continued refinement of aptamer selection and truncation strategies will be crucial for overcoming challenges such as matrix interference and further improving sensitivity to rival that of molecular methods, ensuring that the diagnostic response to MrNV can be as swift and effective as the pathogen itself.

Vaccine Development Using Virus-Like Particle Platforms

The development of efficacious prophylactic interventions against Macrobrachium rosenbergii nodavirus (MrNV) represents one of the most pressing challenges in crustacean aquaculture, given the pathogen's capacity to induce up to 100% mortality in larval and post-larval stages [1, 9, 20]. Conventional vaccine paradigms, predicated upon adaptive immune memory and immunological recall, encounter a fundamental biological obstacle in penaeid and palaemonid species: crustaceans lack the classical adaptive immunity mediated by immunoglobulins, T-cell receptors, and major histocompatibility complexes [10]. Yet, a substantial and growing body of evidence demonstrates that virus-like particle (VLP) platforms derived from the MrNV capsid protein (NvC) circumvent this limitation through mechanisms rooted in innate immune memory, or "trained immunity," and through the potent, multivalent display of antigenic structures that drive robust humoral and cellular responses even in the absence of a canonical adaptive system [10, 15, 18]. The MrNV capsid protein, a 371-amino-acid polypeptide encoded by RNA2, possesses the remarkable intrinsic property of self-assembling into icosahedral particles (T=3 symmetry) of approximately 30 nm in diameter, faithfully recapitulating the architecture of the native virion [12, 14, 22]. This innate self-assembly, coupled with the structural plasticity of the protruding (P) domain, has rendered the MrNV VLP an extraordinarily versatile scaffold for heterologous antigen display, targeted cargo encapsulation, and multivalent vaccine design, a platform that has now been demonstrated across multiple taxonomic classes, from crustaceans to poultry and mammals [3, 35, 36].

Structural Foundations of the MrNV VLP Platform

A prerequisite for rational VLP-based vaccine engineering is a comprehensive understanding of the capsid's atomic architecture. Cryogenic electron microscopy (cryo-EM) reconstructions at resolutions reaching 3.3 Å have elucidated that the MrNV capsid is fundamentally distinct from other members of the Nodaviridae family [14, 22]. Unlike the trimeric spikes characteristic of alphanodaviruses and betanodaviruses, the MrNV capsid assembles with pronounced dimeric blade-like spikes that project up to 6 nm from the shell surface [14, 22]. Each asymmetric unit of the T=3 capsid contains three pairs of Ca²⁺ ions that critically stabilize the shell domain, and an extensive network of N-terminal arms lines the capsid interior, forming long-range interactions that lace together adjacent asymmetric units [14]. This calcium-dependent stabilization has profound implications for VLP production: fluctuations in ionic conditions during recombinant expression or purification can compromise particle integrity, necessitating the careful modulation of buffer composition and the inclusion of calcium chelators or stabilizing agents.

The capsid protein is organized into two discrete functional domains: the shell (S) domain (residues 1–252), which forms the continuous icosahedral scaffold, and the protruding (P) domain (residues 253–371), which assembles into the dimeric spikes [14, 21]. Circular dichroism analysis of the recombinant P-domain reveals that it is composed almost exclusively of β-sheet structures (67.9%), with no detectable α-helical content, a finding in excellent agreement with the cryo-EM data [21]. The P-domain dimerizes with a hydrodynamic diameter of approximately 6 nm and is responsible for host cell attachment, specifically through binding to fucosylated N-glycans on susceptible tissues, including the gills and hemocytes [19, 21]. This glycan-binding property is mediated by lectin-like interactions involving specific amino acid residues within the P-domain, and it can be exploited for targeted delivery or for the design of decoy receptors that competitively inhibit viral attachment [2, 19].

Chimeric VLP Design for Heterologous Antigen Display

The modularity of the MrNV capsid permits the insertion, substitution, or fusion of foreign polypeptides at multiple permissive sites without disrupting the particle's ability to self-assemble. The C-terminus of the capsid protein has been identified as a particularly accommodating location for the display of heterologous antigens. In a landmark demonstration of cross-kingdom vaccine applicability, Thian and colleagues (2025) engineered a chimeric VLP (NvC-2xhuM2e-2xavM2e) in which two copies each of the matrix 2 ectodomain (M2e) from human and avian influenza A viruses were fused to the C-terminus of the MrNV capsid protein [35]. When expressed in insect cells, the fusion protein self-assembled into VLPs that elicited robust M2e-specific antibody responses in White Leghorn chickens. Remarkably, vaccinated chickens challenged with heterologous H9N2 and H5N2 avian influenza viruses displayed significantly reduced weight loss, diminished clinical signs, and substantially lower viral loads in lung tissues compared to unvaccinated controls [35]. Viral shedding from the oropharynx and cloacae was markedly reduced, and the VLPs activated both inflammatory and anti-inflammatory cytokine networks, contributing to enhanced viral clearance while simultaneously mitigating lung and tracheal immunopathology [35]. This study constitutes compelling evidence that the MrNV VLP platform can confer cross-protective immunity against genetically divergent viral strains, a property of immense value for pathogens with high antigenic drift potential.

The platform's versatility extends beyond avian influenza antigens. Ninyio and colleagues (2020) demonstrated that the hepatitis B virus "a" determinant (aD) displayed on MrNV VLPs produced in Sf9 insect cells elicited sustained anti-aD antibody titers in BALB/c mice that were significantly higher than those induced by a commercially available hepatitis B vaccine [36]. Immunophenotyping revealed proliferation of cytotoxic T lymphocytes (CD8⁺) and NK1.1 natural killer cells, and enzyme-linked immunospot (ELISPOT) analysis confirmed the presence of antibody-secreting memory B cells in splenocytes stimulated with the synthetic aD peptide [36]. These findings underscore that the MrNV VLP platform is capable of inducing both humoral and cellular arms of immunity, including the generation of immunological memory, a property that is particularly noteworthy given the crustacean origins of the carrier protein.

The P-domain itself can be extensively modified or completely replaced while retaining icosahedral assembly. Chantunmapitak and colleagues (2025) demonstrated that truncation of the P-domain at sites adjacent to the calcium-binding domains in the S-shell generated smaller, smooth-surfaced icosahedral particles (designated V250-MrNV-VLPs) lacking the characteristic blade-like protrusions [2]. Remarkably, these truncated particles retained the capacity for self-assembly, and the vacant P-domain sites could be fully replaced with heterologous domains, in this case, the fucose-binding carbohydrate-recognition domain (CRD) of CLEC17A lectin (Prolectin) [2]. The resulting chimeric CLEC17A/CRD-MrNV-VLPs were stable, structurally distinct particles that exhibited specific binding to immobilized fucosylated glycoconjugates and Sf9 cell protein lysates. Crucially, these chimeric VLPs competitively reduced MrNV binding and infection in Sf9 cells, functioning as decoy nanoparticles that sequestered the virus away from its natural cellular receptors [2]. This "antiviral decoy" strategy represents a paradigm shift in MrNV prophylaxis: rather than inducing an immune response against the virus, the VLPs themselves act as direct competitive inhibitors of viral attachment.

Interior Modification for Cargo Encapsulation and Targeted Delivery

Beyond surface display, the MrNV VLP can be engineered as a nanocontainer for the encapsulation of therapeutic payloads, including double-stranded RNA (dsRNA) for sequence-specific gene silencing. Muikham and colleagues (2024) rationally redesigned the interior surface of the VLP to enhance the encapsulation efficiency of VP37-dsRNA, a therapeutic targeting white spot syndrome virus (WSSV) in Penaeus vannamei [3]. Two chimeric variants were constructed: V1-MrN-VLP, engineered with an RNA-binding domain (RBD) peptide on the interior surface, and V2-MrN-VLP, engineered with a deca-arginine (10R) peptide. Both variants retained the icosahedral morphology and 30 nm diameter of the parental V0-MrN-VLP, as confirmed by transmission electron microscopy and dynamic light scattering [3]. However, the encapsulation efficiency of VP37-dsRNA was markedly improved in the chimeric variants, with V2-MrN-VLP achieving a 1.4-fold increase in dsRNA loading compared to the parental template. When administered to P. vannamei and subsequently challenged with WSSV, shrimp treated with dsRNA-loaded V1- or V2-MrN-VLPs exhibited significantly reduced VP37 gene expression and lower viral copy numbers compared to those treated with the unmodified V0-MrN-VLP template [3]. This interior engineering approach capitalizes on the inherent affinity between the positively charged arginine residues and the negatively charged phosphate backbone of dsRNA, creating an electrostatic "capture" mechanism that maximizes cargo loading. The implications for MrNV vaccine development are profound: these interior-modified VLPs could be loaded with MrNV-specific dsRNA targeting the RNA-dependent RNA polymerase (RdRp) or capsid protein genes, simultaneously delivering both a protein antigen and a genetic adjuvant in a single nanoparticle.

Enhancing VLP Yield and Stability Through Protease Modulation

One of the principal obstacles to the scalable production of MrNV CP VLPs, particularly in Escherichia coli expression systems, is susceptibility to proteolytic degradation. Selvaraj and colleagues (2021) identified that the primary proteolytic cleavage site occurs at arginine 26 of the MrNV CP, and that the responsible protease is likely a cysteine protease [12]. Through systematic screening of protease inhibitors, the authors demonstrated that the addition of E-64, a specific cysteine protease inhibitor, dramatically improved the yield of intact MrNV CP by 2.3-fold compared to untreated controls [12]. The structural integrity of the VLPs was preserved, as confirmed by transmission electron microscopy, and the particles retained their ability to self-assemble into icosahedral structures [12]. This optimization is not merely a technical convenience; it is a critical requirement for the economic feasibility of large-scale VLP production. For a vaccine platform intended for use in aquaculture, where production costs must be minimized to ensure accessibility for smallholder farmers, any improvement in yield that reduces the cost per dose is of paramount importance. Furthermore, the use of inexpensive, food-grade protease inhibitors or the engineering of protease-resistant capsid variants through site-directed mutagenesis at arginine 26 could further streamline production.

Oral Delivery and the Induction of Mucosal Immunity in Crustaceans

The route of vaccine administration is a decisive factor in the practical implementation of MrNV prophylaxis. Injection-based vaccination, while effective in laboratory settings, is impractical for the millions of post-larvae in a commercial hatchery. Oral delivery, by contrast, offers a scalable, non-invasive, and stress-minimizing approach. Citarasu and colleagues (2019) demonstrated that oral administration of baculovirus-expressed recombinant MrNV capsid protein (r-MrNV), coated onto artificial prawn feed, conferred up to 78% protection against virulent MrNV challenge in M. rosenbergii larvae [18]. Larvae fed the r-MrNV-supplemented diet for 60 days exhibited 65% survival at 30 days post-vaccination (dpv) and 80% survival at 60 dpv, compared to 90% mortality in the unvaccinated control group [18]. Double-step PCR analysis revealed that viral loads were significantly reduced in vaccinated animals, with infection rates dropping from 100% in controls to 32% at 30 dpv and 17% at 60 dpv [18]. Remarkably, the expression of the antimicrobial peptide Mramp, a component of the innate immune response, was upregulated in vaccinated prawns, while unvaccinated controls showed no detectable Mramp expression [18]. This suggests that oral delivery of the VLP-based vaccine stimulates a systemic innate immune response, likely through recognition of the multivalent particulate antigen by pattern recognition receptors in the gut-associated lymphoid tissue of the prawn.

A parallel approach employed a DNA vaccine construct (MrNV-CP-RNA-2-pVAX1) encoding the capsid protein gene, delivered orally via coated feed pellets [15]. Juvenile M. rosenbergii fed the DNA vaccine for 40 days exhibited 60% survival at 20 dpv and 80% survival at 40 dpv following virulent MrNV challenge, while unvaccinated controls succumbed to 100% mortality within 5 days [15]. Hematological parameters including coagulation time, total hemocyte count, and oxyhemocyanin levels were significantly improved in vaccinated prawns, and the activities of prophenol oxidase (ProPO), superoxide anion, and lysozyme were significantly elevated [15]. These findings indicate that the DNA vaccine induces a multifaceted immune response that enhances both cellular and humoral defenses. While the DNA vaccine itself is not a VLP, it underscores the principle that the capsid protein expressed in vivo can self-assemble into VLPs within the host, acting as an endogenous antigen depot that drives prolonged immune stimulation.

Attenuation Strategies and the Path to Live-Attenuated VLP-Based Vaccines

The development of live-attenuated MrNV vaccines has been hampered by concerns regarding reversion to virulence and the lack of immortalized shrimp cell lines for efficient viral propagation [9, 10, 25]. However, Ismail and colleagues (2020) pioneered an innovative attenuation strategy based on codon deoptimization of the viral RNA2 segment encoding the capsid protein [25]. By introducing 125 synonymous codon substitutions (84% nucleotide sequence similarity to wild-type), the authors created a mutant RNA2 that, when co-transfected with wild-type RNA1 into Sf9 cells, produced viral particles with significantly attenuated cytopathogenicity. Sf9 cells transfected with the mutant clone exhibited only minimal cytoplasmic swelling and cellular aggregation, in stark contrast to the pronounced cytopathic effects induced by the wild-type clone [25]. Importantly, the mutant retained infectivity, confirming that attenuation was achieved without complete abrogation of replication. This approach could be combined with VLP technology: the codon-deoptimized capsid protein would self-assemble into VLPs that are structurally indistinguishable from the wild-type virus but are incapable of efficient replication, providing a safe and immunogenic vaccine candidate. The Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH) have both emphasized the need for safe, scalable vaccine platforms for aquatic animal diseases, and codon deoptimization offers a path to meet these regulatory requirements without the risks associated with classical live-attenuated vaccines.

Mechanistic Insights into VLP-Mediated Immune Activation

The mechanisms by which MrNV VLPs induce protective immunity in crustaceans, which lack adaptive immunity, warrant careful consideration. The hematopoietic tissue (Hpt) of M. rosenbergii plays a dual role as a source of hemocyte hematopoiesis and as a defensive organ against MrNV infection [13]. Transcriptomic analysis of MrNV-infected prawns revealed that the crustacean hematopoietic factor (CHF) and cell growth-regulating zinc finger protein (Lyar) are upregulated during infection, driving the production of new hemocytes to replace those lost to viral cytolysis [13]. VLPs, by mimicking the native virion without causing productive infection, may stimulate the Hpt to mount a similar proliferative response, effectively "priming" the hematopoietic system for a subsequent encounter with the live virus. Additionally, the expression of immune-related genes, including antiviral proteins, C-type lectins, prophenol oxidase, caspase, ADP ribosylation factors, and dicer, is significantly altered during MrNV infection [17]. The multivalent, repetitive display of capsid epitopes on the VLP surface is likely to engage pattern recognition receptors (e.g., Toll-like receptors, C-type lectin receptors) more efficiently than soluble monomeric antigens, triggering a stronger and more sustained innate immune response [18]. This concept of trained immunity, whereby prior exposure to a microbial ligand induces epigenetic and metabolic reprogramming of innate immune cells, leading to enhanced responsiveness upon secondary challenge, is now recognized in invertebrates and provides a mechanistic framework for understanding VLP-induced protection in crustaceans [10, 17].

Current Control Strategies and Future Directions

The formidable challenge posed by Macrobrachium rosenbergii nodavirus (MrNV) to global freshwater prawn aquaculture has spurred a multifaceted research effort aimed at developing robust control strategies. These efforts span the continuum from rapid, field-deployable diagnostics to sophisticated prophylactic and therapeutic interventions, each confronting unique biological and logistical hurdles. Current approaches are primarily reactive, focusing on early detection and biosecurity, while the future landscape is being shaped by molecular engineering, structural biology, and a deeper understanding of host-pathogen interactions at the glycan and proteomic levels.

Emerging Diagnostic Platforms: From Laboratory to Field

The cornerstone of any effective disease control program is rapid and accurate diagnosis. Traditional genome-based methods like RT-PCR, while sensitive, are often too costly, time-consuming, and instrument-dependent for routine on-site monitoring in resource-limited hatchery settings. This critical gap is being addressed by a new generation of diagnostic tools designed for simplicity, speed, and affordability.

Aptamer-Based Sensors: A Paradigm Shift in Affinity and Cost. Aptamers, often termed "synthetic antibodies," offer a compelling alternative to conventional antibodies due to their chemical stability, low production cost, and ease of modification. Recent work has demonstrated that single-stranded DNA aptamers selected against the MrNV capsid protein can be integrated into gold nanoparticle (AuNP)-based aptasensors, where the presence of viral protein induces a colorimetric shift detectable by the naked eye [4]. A significant advancement was the discovery that truncating a selected aptamer at the primer overhang dramatically improves its binding affinity, reducing the dissociation constant (Kd) from 347 nM to a remarkable 30.1 nM [1]. This enhanced affinity translated to a lower limit of detection (LoD) of 1.7 nM for the capsid protein, suggesting superior sensitivity for early-stage infection [1]. The practical application of these aptamers in an enzyme-linked aptamer assay (ELASA) and AuNP-based formats has been validated with infected M. rosenbergii tissue lysates, although a critical interference from prawn protein concentration was noted, necessitating careful sample standardization [1]. The path forward for this technology lies in its integration into user-friendly formats like lateral flow assays (LFAs) or dipsticks, which could provide a rapid, cost-effective, and instrument-free solution for hatchery workers [1, 4].

Isothermal Amplification and Immunochromatographic Synergy. Beyond aptamers, the combination of isothermal nucleic acid amplification techniques with lateral flow dipstick (LFD) readouts represents a powerful paradigm for on-site molecular detection. Nucleic acid sequence-based amplification (NASBA) coupled with LFD demonstrated astonishing sensitivity, detecting as little as 1.0 fg of total RNA from MrNV-infected tissue, a sensitivity 10,000-fold greater than conventional RT-PCR [33]. This assay, operating at a constant 41°C for 90 minutes, offers a rapid and specific alternative to thermal cycling. Similarly, a reverse transcription loop-mediated isothermal amplification (RT-LAMP) combined with LFD achieved a sensitivity 100-fold higher than conventional PCR, capable of detecting MrNV and the co-infecting extra small virus (XSV) simultaneously from as little as 1.0 pg of total RNA [23]. A particularly important validation study developed and rigorously optimized an antibody-based LFA for MrNV detection in the post-larval (PL) stage. Using a design of experiment approach, this LFA achieved a limit of detection of 10⁴ particles/ng of total RNA, and critically, demonstrated high sensitivity (100%) and specificity (90%) when validated against qRT-PCR on 80 field samples from hatcheries, with a Cohen's kappa coefficient of 0.936 indicating "good agreement" [34]. This level of field validation is crucial for translating these technologies from the research bench to practical disease management.

Biosecurity and Physical Control Measures

In the absence of widely available therapeutic options for crustaceans, stringent biosecurity remains the first and most critical line of defense. Effective control hinges on the interruption of viral transmission routes, which include waterborne spread, vertical transmission from broodstock, and fomite contamination.

Chemical and Physical Inactivation Protocols. Systematic studies have established a clear framework for inactivating MrNV and XSV in aquaculture settings. Ultraviolet (UV) irradiation for a period of 5 minutes or more has been shown to totally inactivate the viruses, rendering them non-infectious to post-larvae [26]. The viruses are also highly susceptible to alkaline conditions, with pH levels of 8.5, 9, and 10 causing complete inactivation [26]. Among chemical disinfectants, iodine at concentrations of 100 ppm or higher is effective, while sodium hypochlorite, formalin, benzalkonium chloride, and benzethonium chloride require concentrations of 200 ppm to achieve 100% mortality in challenge models [26]. These findings provide evidence-based protocols for disinfecting equipment, tanks, and water sources. Furthermore, a comprehensive disease control program in an Indonesian hatchery, involving the disinfection of all stages, post-larvae, broodstocks, water media, tanks, equipment, and ponds, successfully eradicated white tail disease (WTD) from the facility, demonstrating that rigorous biosecurity can be effective on a farm scale [24]. This integrated approach, while labor-intensive, remains a cornerstone of current control strategies.

Prophylactic Strategies: Vaccination and Immune Modulation

The concept of vaccinating crustaceans, which lack a classical adaptive immune system, was once considered scientifically dubious. However, a growing body of evidence demonstrates that immune priming or "trained immunity" in invertebrates can confer significant protection against viral challenges. This has opened a new frontier for MrNV prophylaxis.

DNA and Subunit Vaccines: Proof-of-Concept and Mechanisms. A landmark study demonstrated that a DNA vaccine construct expressing the MrNV capsid protein (MrNV-CP-RNA-2-pVAX1), delivered orally via coated feed pellets, conferred substantial protection. Vaccinated M. rosenbergii juveniles showed 60% and 80% survival rates following virulent MrNV challenge at 20- and 40-days post-vaccination (dpv), respectively, compared to 100% mortality in controls [15]. The protective mechanism was associated with significant improvements in hematological parameters, including increased total hemocyte count (THC) and oxyhemocyanin levels, as well as enhanced immune enzyme activities such as prophenol oxidase (ProPO) and superoxide anion production [15]. Complementing this, an oral subunit vaccine using baculovirus-expressed MrNV capsid protein, which self-assembled into virus-like particles (VLPs), provided up to 78% protection. This study also revealed that the antimicrobial peptide gene Mramp was successfully expressed only in vaccinated prawns, suggesting a specific molecular signature of the protective immune response [18]. These results collectively challenge the dogma that crustaceans cannot be vaccinated and point towards a mechanism of innate immune memory, likely mediated by hemocyte reprogramming.

The VLP Platform: A Versatile Scaffold for Immunization and Delivery. The MrNV capsid protein possesses an extraordinary ability to self-assemble into stable, 30 nm icosahedral VLPs when expressed in heterologous systems like E. coli and insect cells [12, 22, 30]. This property has been exploited not only for direct vaccination but also as a modular platform for antigen display and therapeutic delivery. The chimeric VLP approach has proven remarkably versatile. For instance, VLPs displaying the hepatitis B virus "a" determinant elicited a stronger and more sustained antibody response in mice than a commercial hepatitis B vaccine, underscoring their potency as an antigen presentation scaffold [36]. In a striking example of cross-species applicability, MrNV-VLPs displaying the M2e ectodomain of influenza A viruses protected chickens against heterologous H9N2 and H5N2 challenges, demonstrating the platform's potential for poultry vaccine development [35].

For MrNV itself, a critical bottleneck has been the recombinant capsid protein's vulnerability to proteolytic degradation, particularly by a cysteine protease cleaving at arginine 26. The strategic addition of the cysteine protease inhibitor E-64 to the E. coli expression system dramatically improved the yield of intact, stable capsid protein by 2.3-fold [12]. This innovative approach is essential for scaling up VLP production for commercial vaccine development. Furthermore, the VLP interior has been engineered for therapeutic cargo delivery. By inserting RNA-binding domains (RBD) or deca-arginine (10R) peptides onto the interior surface, the encapsulation efficiency of antiviral VP37-dsRNA (active against white spot syndrome virus) was improved 1.4-fold, leading to significantly better protection against WSSV challenge in P. vannamei [3]. This dual-use VLP platform, acting as both an immunogen and a nanocontainer, represents a powerful, multi-functional tool for future disease control.

Live-Attenuated Vaccine Development: A Cautious Path Forward. The potential of live-attenuated vaccines remains a topic of active discussion. To date, no live-attenuated MrNV vaccine has been experimentally tested in prawns [10]. However, a critical proof-of-concept study demonstrated that codon deoptimization of the viral capsid protein-encoding gene (RNA2) can successfully attenuate MrNV. A mutant RNA2 containing 125 synonymous codon substitutions (84% nucleotide identity to wild-type) produced significantly reduced cytopathic effects in Sf9 insect cells, including less cytoplasmic swelling and cellular aggregation, compared to the wild-type clone [25]. This approach offers a rational, sequence-based method for generating attenuated virus strains. While the safety and efficacy of such a mutant in a live vaccine for M. rosenbergii remain to be tested, the strategy provides a potential pathway. The primary concern, as with any live RNA virus vaccine, is the risk of reversion to virulence or recombination with field strains, particularly in the open aquatic environment.

Antiviral Strategies: Targeting Viral Entry and Replication

The detailed structural characterization of MrNV has opened new avenues for rational drug design, moving beyond empirical screening to target-specific antiviral development.

Peptide Inhibitors: Blocking the First Step of Infection. A seminal study using a 12-mer phage-displayed peptide library panned against MrNV VLPs identified two dominant binding peptides: HTKQIPRHIYSA and VSRHQSWHPHDL [31]. These synthetic peptides inhibited VLP entry into Sf9 cells with IC₅₀ values of approximately 30.4 and 26.5 µM, respectively. Remarkably, the combination of both peptides exhibited a synergistic effect, reducing the IC₅₀ to 4.9 µM, and restoring cell viability to ~97% in infected cultures [31]. Quantitative RT-PCR confirmed that the peptide cocktail reduced the viral load per cell by nearly 90% (from 97 to 11 copies per cell) [31]. These peptides are believed to function by competing with the viral P-domain for host cell receptors, specifically by interfering with attachment to fucosylated glycans, which have been identified as critical binding molecules for MrNV in susceptible tissues like gills [19, 31]. The structural basis for this interaction lies in the unique dimeric, blade-like protruding (P) domains of the MrNV capsid, which differ fundamentally from the trimeric spikes of other nodaviruses [14, 22]. The high-resolution cryo-EM structure of the capsid, revealing a network of N-terminal arms and stabilization by Ca²⁺ ions, provides an atomic-level roadmap for designing more potent competitive inhibitors [14].

Targeting the Viral Replication Machinery. The RNA-dependent RNA polymerase (RdRp) of MrNV, an essential enzyme for genome replication, represents a high-value drug target. Structural modeling of MrNV RdRp (MnRdRp) using AlphaFold2 revealed a classic "fingers-palm-thumb" architecture common to other positive-sense RNA viruses, with the palm domain being the most evolutionarily conserved [5]. The identification of conserved metal-binding residues (Asp599, Asp704, Asp705) and the 2'-OH recognition network (Asp604, Ser661, Asn670) provides a framework for designing nucleoside analog inhibitors [5]. A significant finding from molecular docking studies was that Dasabuvir, a non-nucleoside inhibitor approved for hepatitis C virus (HCV, a Flaviviridae member), can potentially bind to and inhibit MnRdRp, suggesting that repurposing existing antiviral drugs may be a viable strategy [5]. The structural similarity between MnRdRp and flaviviral polymerases further implies that other inhibitors from this class could be screened for anti-MrNV activity [5]. This approach, leveraging computational drug repurposing, could dramatically accelerate the timeline for developing therapeutic options.

Alternative and Complementary Approaches

Beyond direct antiviral and vaccination strategies, a deeper understanding of host immunity and viral pathogenesis is revealing novel intervention points.

Harnessing Innate Immunity and the Hematopoietic System. The observation that adult M. rosenbergii are resistant to MrNV infection, while post-larvae are highly susceptible, is a critical clue for therapeutic development. Transcriptomic analysis of the hematopoietic tissue (Hpt) revealed that adult prawns respond to MrNV infection by upregulating genes involved in hemocyte hematopoiesis, such as crustacean hematopoietic factor (CHF) and cell growth-regulating zinc finger protein (Lyar), coincident with the activation of humoral immune factors like anti-lipopolysaccharide factor (ALF) [13]. This suggests that the resistance of adults is not due to a lack of viral receptors but rather an enhanced capacity to replenish hemocytes and mount a rapid immune response. This insight opens the possibility of developing immunostimulants that can "prime" the Hpt of post-larvae, accelerating their hemocyte production and immune gene expression to a level that can withstand MrNV challenge. Such an approach would target the host's resilience rather than the pathogen directly.

Glycan-Based Decoys and Receptor Mimetics. The discovery that MrNV-VLPs preferentially bind to fucosylated N-glycans on gill tissues, and that this binding can be blocked by the fucose-binding lectin AAL, offers a potential decoy strategy [19]. Furthermore, chimeric VLPs engineered to display the carbohydrate-recognition domain (CRD) of CLEC17A lectin (Prolectin) successfully bound to these fucosylated glycans and, importantly, significantly reduced MrNV infection in Sf9 cells [2]. This "Trojan horse" approach, where non-infectious VLPs competitively block viral attachment sites, represents a novel prophylactic strategy. The success of engineering the CLEC17A/CRD-MrNV-VLPs, which maintained icosahedral integrity while displaying distinct P-domains, validates the concept of creating stable, multivalent glycan-binding nanoparticles as antiviral agents [2].

Future Directions and Critical Gaps

Looking forward, several critical gaps must be addressed to translate these promising laboratory findings into practical field solutions. First, the development of an immortalized shrimp cell line remains the single most important unmet need in crustacean virology [9]. Such a cell line would revolutionize viral propagation for vaccine production, enable high-throughput antiviral screening, and facilitate detailed mechanistic studies of viral replication and pathogenesis. Second, the mechanisms underlying innate immune memory or "trained immunity" in crustaceans require molecular elucidation. Identifying the specific hemocyte subpopulations, epigenetic marks, and signaling pathways involved would allow for the rational design of more effective vaccines and immunostimulants. Third, the practical delivery of nucleic acid-based therapies (e.g., aptamers, dsRNA, DNA vaccines) in the aquatic environment remains a significant hurdle

References

[1] Ghadin N, Baharum S, Raston NHA, Low C. Truncation-Enhanced Aptamer Binding Affinity and Its Potential as a Sensor for Macrobrachium rosenbergii Nodavirus Detection.. Journal of Fish Diseases. 2025. DOI: https://doi.org/10.1111/jfd.14093

[2] Chantunmapitak R, Boonkua S, Thongsum O, Breiman A, Weerachatyanukul W, Asuvapongpatana S, et al.. Chimeric virus-like particles carrying the CLEC17A carbohydrate-recognition domain significantly reduce Macrobrachium rosenbergii nodavirus infection in Sf9 cells. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-27357-3

[3] Muikham I, Thongsum O, Jaranathummakul S, Wathammawut A, Chotwiwatthanakun C, Jariyapong P, et al.. Interior modification of Macrobrachium rosenbergii nodavirus-like particle enhances encapsulation of VP37-dsRNA against shrimp white spot syndrome infection. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-024-03936-w

[4] Ghadin N, Yusof NAM, Nataqain BS, Raston NHA, Low C. Selection and characterization of ssDNA aptamer targeting Macrobrachium rosenbergii nodavirus capsid protein: A potential capture agent in gold-nanoparticle-based aptasensor for viral protein detection.. Journal of Fish Diseases. 2023. DOI: https://doi.org/10.1111/jfd.13892

[5] Kumar G, Singh A, Agarwal D. Structural and functional characterization of RNA dependent RNA polymerase of Macrobrachium rosenbergii nodavirus (MnRdRp).. Journal of Biomolecular Structure and Dynamics. 2023. DOI: https://doi.org/10.1080/07391102.2023.2175384

[6] Jang G, Kim BS, Kim SM, Oh Y, Kim JO, Hwang J, et al.. Detection of Macrobrachium rosenbergii Nodavirus (MrNV) of White Tail Disease (WTD) in Apparently Healthy Giant Freshwater Prawn, Macrobrachium rosenbergii in Korea. Fishes. 2022. DOI: https://doi.org/10.3390/fishes7050294

[7] Weerachatyanukul W, Pooljun C, Hirono I, Chotwiwatthanakun C, Jariyapong P. Infectivity and virulence of the infectious Macrobrachium rosenbergii nodavirus produced from Drosophila melanogaster cell using Penaeus merguiensis as an infection model.. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.108474

[8] . Macrobrachium rosenbergii nodavirus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.121699

[9] Chen K, Tan W, Ong L, Abidin SZZ, Othman I, Tey B, et al.. The Macrobrachium rosenbergii nodavirus: a detailed review of structure, infectivity, host immunity, diagnosis and prevention. Reviews in Aquaculture. 2021. DOI: https://doi.org/10.1111/RAQ.12562

[10] Chen-Fei L, Chou-Min C, Jiun-Yan L. Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn.. Fish and Shellfish Immunology. 2020. DOI: https://doi.org/10.1016/j.fsi.2020.06.039

[11] Gangnonngiw W, Bunnontae M, Phiwsaiya K, Senapin S, Dhar A. In experimental challenge with infectious clones of Macrobrachium rosenbergii nodavirus (MrNV) and extra small virus (XSV), MrNV alone can cause mortality in freshwater prawn (Macrobrachium rosenbergii).. Virology. 2019. DOI: https://doi.org/10.1016/j.virol.2019.11.004

[12] Selvaraj BA, Mariatulqabtiah AR, Ho KL, Ng C, Yong CY, Tan W. Regulation of Proteolytic Activity to Improve the Recovery of Macrobrachium rosenbergii Nodavirus Capsid Protein. International Journal of Molecular Sciences. 2021. DOI: https://doi.org/10.3390/ijms22168725

[13] Jariyapong P, Pudgerd A, Cheloh N, Hirono I, Kondo H, Vanichviriyakit R, et al.. Hematopoietic tissue of Macrobrachium rosenbergii plays dual roles as a source of hemocyte hematopoiesis and as a defensive mechanism against Macrobrachium rosenbergii nodavirus infection. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2018.12.021

[14] Ho KL, Gabrielsen M, Beh PL, Kueh CL, Thong QX, Streetley J, et al.. Structure of the Macrobrachium rosenbergii nodavirus: A new genus within the Nodaviridae?. bioRxiv. 2018. DOI: https://doi.org/10.1371/journal.pbio.3000038

[15] Citarasu T, Lelin C, Thirumalaikumar E, Babu MM, Vakharia V. Macrobrachium rosenbergii nodavirus (MrNV)‐CP‐RNA‐2 DNA vaccine confers protective immunity in giant freshwater prawn Macrobrachium rosenbergii against MrNV infection. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2018.11.049

[16] Astani EK, Chen N, Huang Y, Ersali S, Lin P, Guan H, et al.. Characterization of Dimeric Interactions within Protrusion-Domain Interfaces of Parallel and X-Shaped Conformations of Macrobrachium rosenbergii Nodavirus: A Theoretical Study Using the DFT Method along with QTAIM and NBO Analyses. ACS Omega. 2020. DOI: https://doi.org/10.1021/acsomega.9b03697

[17] Pasookhush P, Hindmarch C, Sithigorngul P, Longyant S, Bendena W, Chaivisuthangkura P. Transcriptomic analysis of Macrobrachium rosenbergii (giant fresh water prawn) post-larvae in response to M. rosenbergii nodavirus (MrNV) infection: de novo assembly and functional annotation. BMC Genomics. 2019. DOI: https://doi.org/10.1186/s12864-019-6102-6

[18] Citarasu T, Lelin C, Babu M, Anand SB, Nathan AA, Vakharia V. Oral vaccination of Macrobrachium rosenbergii with baculovirus‐expressed M. rosenbergii nodavirus (MrNV) capsid protein induces protective immunity against MrNV challenge. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2018.12.010

[19] Somrit M, Yu S, Pendu JL, Breiman A, Guérardel Y, Weerachatyanukul W, et al.. Macrobrachium rosenbergii nodavirus virus‐like particles attach to fucosylated glycans in the gills of the giant freshwater prawn. Cellular Microbiology. 2020. DOI: https://doi.org/10.1111/cmi.13258

[20] Low C, Yusoff MRM, Kuppusamy G, Nadzri NFA. Molecular biology of Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn.. Journal of Fish Diseases. 2018. DOI: https://doi.org/10.1111/jfd.12895

[21] Chong L, Ganesan H, Yong CY, Tan W, Ho KL. Expression, purification and characterization of the dimeric protruding domain of Macrobrachium rosenbergii nodavirus capsid protein expressed in Escherichia coli. PLoS ONE. 2019. DOI: https://doi.org/10.1371/journal.pone.0211740

[22] Ho KL, Kueh CL, Beh PL, Tan W, Bhella D. Cryo-Electron Microscopy Structure of the Macrobrachium rosenbergii Nodavirus Capsid at 7 Angstroms Resolution. Scientific Reports. 2017. DOI: https://doi.org/10.1038/s41598-017-02292-0

[23] Lin F, Liu L, Hao G, Sheng P, Cao Z, Zhou Y, et al.. The development and application of a duplex reverse transcription loop-mediated isothermal amplification assay combined with a lateral flow dipstick method for Macrobrachium rosenbergii nodavirus and extra small virus isolated in China.. Molecular and Cellular Probes. 2018. DOI: https://doi.org/10.1016/j.mcp.2018.05.001

[24] Murwantoko M, Bimantara A, Roosmanto R, Kawaichi M. Macrobrachium rosenbergii nodavirus infection in a giant freshwater prawn hatchery in Indonesia. SpringerPlus. 2016. DOI: https://doi.org/10.1186/s40064-016-3127-z

[25] Ismail SNB, Baharum S, Chee H, Low C. Codon deoptimization of the viral capsid protein-encoding gene attenuates Macrobrachium rosenbergii nodavirus. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.735631

[26] Ravi M, Hameed ASS. Effect of chemical and physical treatments on the inactivation of Macrobrachium rosenbergii nodavirus and extra small virus.. Aquaculture Research. 2016. DOI: https://doi.org/10.1111/ARE.12580

[27] Koesharyani I, Gardenia L. DETECTION OF Macrobrachium rosenbergii Nodavirus (MrNV) AND EXTRA SMALL VIRUS (XSV) DISEASES ON GIANT FRESHWATER PRAWN, Macrobrachium rosenbergii AT SAMAS, YOGYAKARTA. Indonesian Aquaculture Journal. 2014. DOI: https://doi.org/10.15578/IAJ.9.1.2014.33-40

[28] Shekhar MS, Sahoo P, DilliKumar M, Das A. Cloning, expression and sequence analysis of Macrobrachium rosenbergii nodavirus genes: Indian isolate. Aquaculture Research. 2011. DOI: https://doi.org/10.1111/J.1365-2109.2010.02775.X

[29] Xia J, Wang C, Yao L, Wang W, Zhao W, Jia T, et al.. Investigation on Natural Infection of Covert Mortality Nodavirus in Farmed Giant Freshwater Prawn (Macrobrachium rosenbergii). Animals. 2022. DOI: https://doi.org/10.3390/ani12111370

[30] Hanapi UF, Yong CY, Goh ZH, Alitheen N, Yeap S, Tan W. Tracking the virus-like particles of Macrobrachium rosenbergii nodavirus in insect cells. PeerJ. 2017. DOI: https://doi.org/10.7717/peerj.2947

[31] Thong QX, Wong CL, Ooi MK, Kueh CL, Ho KL, Alitheen N, et al.. Peptide inhibitors of Macrobrachium rosenbergii nodavirus.. Journal of General Virology. 2018. DOI: https://doi.org/10.1099/jgv.0.001116

[32] Somrit M, Watthammawut A, Chotwiwatthanakun C, Weerachatyanukul W. The key molecular events during Macrobrachium rosenbergii nodavirus (MrNV) infection and replication in Sf9 insect cells. Virus Research. 2016. DOI: https://doi.org/10.1016/j.virusres.2016.06.012

[33] Lin F, Shen J, Liu Y, Huang A, Zhang H, Chen F, et al.. Rapid and effective detection of Macrobrachium rosenbergii nodavirus using a combination of nucleic acid sequence-based amplification test and immunochromatographic strip.. Journal of Invertebrate Pathology. 2023. DOI: https://doi.org/10.1016/j.jip.2023.107921

[34] Jamalpure S, Vimal S, Ahmed AN, Hameed A, Paknikar K, Rajwade J. On-site detection of nodavirus in post larval (PL) stage of the giant prawn, Macrobrachium rosenbergii: A test to nip the problem in the bud. Aquaculture. 2021. DOI: https://doi.org/10.1016/j.aquaculture.2020.736292

[35] Thian BYZ, Fatimah MNN, Omar AR, Hussin H, Ong HK, Wong CL, et al.. Virus-like particles of Macrobrachium rosenbergii nodavirus displaying M2e of influenza A viruses protect White Leghorn chickens against heterologous H9N2 and H5N2 challenges.. Developmental and Comparative Immunology. 2025. DOI: https://doi.org/10.1016/j.dci.2025.105526

[36] Ninyio N, Ho KL, Ong HK, Yong CY, Chee H, Hamid M, et al.. Immunological Analysis of the Hepatitis B Virus “a” Determinant Displayed on Chimeric Virus-Like Particles of Macrobrachium rosenbergii Nodavirus Capsid Protein Produced in Sf9 Cells. Vaccines. 2020. DOI: https://doi.org/10.3390/vaccines8020275